Uploaded November 2025 | Updated September 2026, 3 days ago
For the third episode of our highlights from the EASD Annual Meeting 2025 in Vienna series, we invited Dr. Sindre Lee-Ødegård. Dr. Lee-Ødegård is a medical doctor as well as a senior researcher at the University of Oslo in Norway and his highlights range from insulin resistance to heart health.
In his presentation, Dr. Lee-Ødegård shares insights on:
- Precision medicine and personalised treatment based on genetics and tissue-specific insulin resistance
- Insulin resistance as the fundamental defect in type 2 diabetes with systemic effects beyond blood sugar
- GlP-1RAs are beneficial for weight management, blood sugar levels AND heart health
- Holistic treatment approach to take diabetes distress into account as emotional health leads to improved glycaemic control
#diabetes #type2diabetes #insulinresistance #EASD2025 #diabetesdistress #precisionmedicine #diabetesresearch
For the third episode of our highlights from the EASD Annual Meeting 2025 in Vienna series, we invited Dr. Sindre Lee-Ødegård. Dr. Lee-Ødegård is a medical doctor as well as a senior researcher at the University of Oslo in Norway and his highlights range from insulin resistance to heart health.
In his presentation, Dr. Lee-Ødegård shares insights on:
- Precision medicine and personalised treatment based on genetics and tissue-specific insulin resistance
- Insulin resistance as the fundamental defect in type 2 diabetes with systemic effects beyond blood sugar
- GlP-1RAs are beneficial for weight management, blood sugar levels AND heart health
- Holistic treatment approach to take diabetes distress into account as emotional health leads to improved glycaemic control
#diabetes #type2diabetes #insulinresistance #EASD2025 #diabetesdistress #precisionmedicine #diabetesresearch










